Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1970 1
1972 2
1974 1
1976 1
1977 2
1979 1
1980 2
1981 2
1982 2
1983 4
1984 7
1985 5
1986 8
1987 10
1988 12
1989 14
1990 11
1991 20
1992 13
1993 12
1994 14
1995 10
1996 16
1997 20
1998 16
1999 15
2000 20
2001 23
2002 29
2003 29
2004 27
2005 34
2006 35
2007 53
2008 49
2009 45
2010 54
2011 85
2012 79
2013 78
2014 98
2015 124
2016 95
2017 100
2018 96
2019 99
2020 100
2021 92
2022 85
Text availability
Article attribute
Article type
Publication date

Search Results

1,572 results
Results by year
Filters applied: . Clear all
Page 1
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Marabelle A, Fakih M, Lopez J, Shah M, Shapira-Frommer R, Nakagawa K, Chung HC, Kindler HL, Lopez-Martin JA, Miller WH Jr, Italiano A, Kao S, Piha-Paul SA, Delord JP, McWilliams RR, Fabrizio DA, Aurora-Garg D, Xu L, Jin F, Norwood K, Bang YJ. Marabelle A, et al. Among authors: kao s. Lancet Oncol. 2020 Oct;21(10):1353-1365. doi: 10.1016/S1470-2045(20)30445-9. Epub 2020 Sep 10. Lancet Oncol. 2020. PMID: 32919526 Clinical Trial.
Immune checkpoint inhibitor-related hepatotoxicity: A review.
Remash D, Prince DS, McKenzie C, Strasser SI, Kao S, Liu K. Remash D, et al. Among authors: kao s. World J Gastroenterol. 2021 Aug 28;27(32):5376-5391. doi: 10.3748/wjg.v27.i32.5376. World J Gastroenterol. 2021. PMID: 34539139 Free PMC article. Review.
ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer.
Shaw AT, Solomon BJ, Besse B, Bauer TM, Lin CC, Soo RA, Riely GJ, Ou SI, Clancy JS, Li S, Abbattista A, Thurm H, Satouchi M, Camidge DR, Kao S, Chiari R, Gadgeel SM, Felip E, Martini JF. Shaw AT, et al. Among authors: kao s. J Clin Oncol. 2019 Jun 1;37(16):1370-1379. doi: 10.1200/JCO.18.02236. Epub 2019 Mar 20. J Clin Oncol. 2019. PMID: 30892989 Free PMC article. Clinical Trial.
Estrogen, Estrogen Receptor and Lung Cancer.
Hsu LH, Chu NM, Kao SH. Hsu LH, et al. Among authors: kao sh. Int J Mol Sci. 2017 Aug 5;18(8):1713. doi: 10.3390/ijms18081713. Int J Mol Sci. 2017. PMID: 28783064 Free PMC article. Review.
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors.
Luke JJ, Barlesi F, Chung K, Tolcher AW, Kelly K, Hollebecque A, Le Tourneau C, Subbiah V, Tsai F, Kao S, Cassier PA, Khasraw M, Kindler HL, Fang H, Fan F, Allaire K, Patel M, Ye S, Chao DT, Henner WR, Hayflick JS, McDevitt MA, Fong L. Luke JJ, et al. Among authors: kao s. J Immunother Cancer. 2021 Feb;9(2):e002015. doi: 10.1136/jitc-2020-002015. J Immunother Cancer. 2021. PMID: 33608377 Free PMC article. Clinical Trial.
1,572 results